Global Donor Egg IVF (In-Vitro Fertilization) Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Donor Egg IVF (In-Vitro Fertilization) Market Research Report 2024
In vitro fertilization (IVF) is a complex series of procedures used to treat fertility or genetic problems and assist with the conception of a child. During IVF, mature eggs are collected (retrieved) from your ovaries and fertilized by sperm in a lab. Then the fertilized egg (embryo) or eggs are implanted in your uterus. One cycle of IVF takes about two weeks.
According to Mr Accuracy reports’s new survey, global Donor Egg IVF (In-Vitro Fertilization) market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Donor Egg IVF (In-Vitro Fertilization) market research.
Key companies engaged in the Donor Egg IVF (In-Vitro Fertilization) industry include OvaScience, EMD Serono Inc., Vitrolife AB, Irvine Scientific, Cook Medical Inc., Cooper Surgical Inc., Genea Biomedx, Thermo Fisher Scientific Inc. and Progyny Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Donor Egg IVF (In-Vitro Fertilization) were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Donor Egg IVF (In-Vitro Fertilization) market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Donor Egg IVF (In-Vitro Fertilization) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
OvaScience
EMD Serono Inc.
Vitrolife AB
Irvine Scientific
Cook Medical Inc.
Cooper Surgical Inc.
Genea Biomedx
Thermo Fisher Scientific Inc.
Progyny Inc.
Boston IVF
Segment by Type
Fresh Donor Egg Cycle
Frozen Donor Egg Cycle
Direct / Patient
Hospitals
Fertility Clinics & IVF Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Donor Egg IVF (In-Vitro Fertilization) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Donor Egg IVF (In-Vitro Fertilization) market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Donor Egg IVF (In-Vitro Fertilization) market research.
Key companies engaged in the Donor Egg IVF (In-Vitro Fertilization) industry include OvaScience, EMD Serono Inc., Vitrolife AB, Irvine Scientific, Cook Medical Inc., Cooper Surgical Inc., Genea Biomedx, Thermo Fisher Scientific Inc. and Progyny Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Donor Egg IVF (In-Vitro Fertilization) were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Donor Egg IVF (In-Vitro Fertilization) market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Donor Egg IVF (In-Vitro Fertilization) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
OvaScience
EMD Serono Inc.
Vitrolife AB
Irvine Scientific
Cook Medical Inc.
Cooper Surgical Inc.
Genea Biomedx
Thermo Fisher Scientific Inc.
Progyny Inc.
Boston IVF
Segment by Type
Fresh Donor Egg Cycle
Frozen Donor Egg Cycle
Segment by Application
Direct / Patient
Hospitals
Fertility Clinics & IVF Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Donor Egg IVF (In-Vitro Fertilization) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source